OraSure Technologies Inc (OSUR)
5.50
-0.03
(-0.54%)
USD |
NASDAQ |
Apr 24, 16:00
5.495
0.00 (0.00%)
After-Hours: 20:00
OraSure Technologies Enterprise Value: 115.47M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 115.47M |
| April 23, 2024 | 117.69M |
| April 22, 2024 | 104.40M |
| April 19, 2024 | 99.24M |
| April 18, 2024 | 97.02M |
| April 17, 2024 | 97.02M |
| April 16, 2024 | 94.81M |
| April 15, 2024 | 108.83M |
| April 12, 2024 | 116.95M |
| April 11, 2024 | 135.40M |
| April 10, 2024 | 136.87M |
| April 09, 2024 | 147.21M |
| April 08, 2024 | 146.47M |
| April 05, 2024 | 149.42M |
| April 04, 2024 | 153.11M |
| April 03, 2024 | 165.65M |
| April 02, 2024 | 153.11M |
| April 01, 2024 | 158.27M |
| March 28, 2024 | 163.44M |
| March 27, 2024 | 162.70M |
| March 26, 2024 | 158.27M |
| March 25, 2024 | 168.61M |
| March 22, 2024 | 175.99M |
| March 21, 2024 | 177.46M |
| March 20, 2024 | 190.74M |
| Date | Value |
|---|---|
| March 19, 2024 | 206.24M |
| March 18, 2024 | 211.41M |
| March 15, 2024 | 200.34M |
| March 14, 2024 | 217.31M |
| March 13, 2024 | 228.38M |
| March 12, 2024 | 230.59M |
| March 11, 2024 | 219.53M |
| March 08, 2024 | 243.14M |
| March 07, 2024 | 247.57M |
| March 06, 2024 | 223.95M |
| March 05, 2024 | 226.17M |
| March 04, 2024 | 218.05M |
| March 01, 2024 | 246.09M |
| February 29, 2024 | 240.56M |
| February 28, 2024 | 280.04M |
| February 27, 2024 | 228.38M |
| February 26, 2024 | 226.91M |
| February 23, 2024 | 223.22M |
| February 22, 2024 | 202.97M |
| February 21, 2024 | 216.20M |
| February 20, 2024 | 211.05M |
| February 16, 2024 | 205.91M |
| February 15, 2024 | 216.20M |
| February 14, 2024 | 219.88M |
| February 13, 2024 | 222.82M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
84.86M
Minimum
Jun 13 2022
1.145B
Maximum
Aug 05 2020
404.53M
Average
359.38M
Median
Mar 03 2023
Enterprise Value Benchmarks
| Abbott Laboratories | 193.10B |
| Integra Lifesciences Holdings Corp | 3.500B |
| Insulet Corp | 12.41B |
| Perspective Therapeutics Inc | 984.38M |
| Xtant Medical Holdings Inc | 131.97M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 20.07M |
| Revenue (Quarterly) | 75.88M |
| Total Expenses (Quarterly) | 68.66M |
| EPS Diluted (Quarterly) | 0.27 |
| Gross Profit Margin (Quarterly) | 46.29% |
| Profit Margin (Quarterly) | 26.45% |
| Earnings Yield | 13.09% |
| Operating Earnings Yield | 10.65% |
| Normalized Earnings Yield | 15.37 |